Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2025-02-14 00:00:00 ET · period of report 2025-02-14 · accession 0001415889-25-004249 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-14 | 2025-02-14 | FENC | RALLIS CHRIS A | Dir | S - Sale+OE | $6.82 | -1,186 | 53.0K | -2% | -$8,089 |
| D | 2025-02-14 | 2025-02-14 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $2.51 | +1,992 | 54.2K | +4% | +$5,000 |
| D | 2025-02-14 | 2025-02-14 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $2.51 | -1,992 | 182.7K | -1% | -$5,000 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-02-14 | S | D | 1,186 | $6.82 | 53,020 | D | — | — | (F2) Shares sold to satisfy tax obligation on option exercise. |
| 2 | Common | Common Shares | 2025-02-14 | M | A | 1,992 | $2.51 | 54,206 | D | — | — | (F1) Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on August 17, 2023. |
| 3 | Derivative | Common Shares | 2025-02-14 | M | D | 1,992 | $2.51 | 182,706 | D | $2.51 · 2015-03-16 to 2025-03-16 | 1,992 Options | (F3) Represents options exercised pursuant to a 10b5-1 plan adopted on August 17, 2023. |